Company / Free Cash Flow per Share
Oric Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$1.27
FY2025
5-year range
-$1.95 / -$1.27
FY2021-FY2025
Trend
+22.1%
vs FY2024
Sector context
#113 of 192
Health Care
What the data says
At $-1.27, Oric Pharmaceuticals, Inc.'s free cash flow per share ranks #113 of 192 in the Health Care sector. Free Cash Flow per Share has increased for 3 consecutive years, from $-1.95 in FY2022 to $-1.27 in FY2025.
Based on SEC 10-K filings.
-1.27 in FY2025.
Improved from $-1.68 to $-1.27 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#113 of 192 in Health CareTop 59% of 192This company -$1.27 Sector average -$19.84
▼
+93.6% above sector average
Key checks
Key Insights
- Oric Pharmaceuticals, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 22.1% year-over-year.
- Ranks #113 out of 192 companies in the Health Care sector.
- Lowest free cash flow per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.27 | +22.1% |
| FY2024 | -$1.63 | +2.9% |
| FY2023 | -$1.68 | +13.6% |
| FY2022 | -$1.95 | -22.2% |
| FY2021 | -$1.59 | +23.9% |
| FY2020 | -$2.09 | +83.6% |
| FY2019 | -$12.79 | -4.6% |
| FY2018 | -$12.23 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026